Skip to Content

Välkommen till lungcancer

Få de senaste artiklarna och MEDtalks om lungcancer.

Senaste nytt om lung cancer

First-Line Lorlatinib in ALK-Positive NSCLC

april 2026 / Jon Alexander Lykkegaard Andersen

First-Line Cemiplimab + Chemotherapy Improves Quality of Life and Delays Disease Deterioration in Advanced NSCLC Without Driver Mutations

april 2026 / Jan Andreasen

ELCC26 Lungcancer

Lung Cancer Highlights

MEDtalks

Artiklar

Back to top